KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Cash from Operations (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Cash from Operations for 16 consecutive years, with 4916000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 198.84% to 4916000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 20115000.0, a 138.58% increase, with the full-year FY2025 number at 20115000.0, up 138.58% from a year prior.
  • Cash from Operations was 4916000.0 for Q4 2025 at Biolife Solutions, down from 6104000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 7857000.0 in Q4 2022 to a low of 9917000.0 in Q2 2022.
  • A 5-year average of 148350.0 and a median of 1686000.0 in 2024 define the central range for Cash from Operations.
  • Biggest YoY gain for Cash from Operations was 1115.12% in 2022; the steepest drop was 535.38% in 2022.
  • Biolife Solutions' Cash from Operations stood at 774000.0 in 2021, then skyrocketed by 1115.12% to 7857000.0 in 2022, then crashed by 70.59% to 2311000.0 in 2023, then dropped by 28.82% to 1645000.0 in 2024, then surged by 198.84% to 4916000.0 in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Cash from Operations are 4916000.0 (Q4 2025), 6104000.0 (Q3 2025), and 7368000.0 (Q2 2025).